Holen Sie sich die Stockscreener-App
37.55
1.12%
-0.43
Schlusskurs vom Vortag:
$37.98
Offen:
$37.86
24-Stunden-Volumen:
1.28M
Relative Volume:
0.29
Marktkapitalisierung:
$4.24B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-99.15M
KGV:
-40.38
EPS:
-0.93
Netto-Cashflow:
$-74.25M
1W Leistung:
+10.85%
1M Leistung:
+2.13%
6M Leistung:
+36.22%
1J Leistung:
-25.41%
1-Tages-Spanne:
$37.30
$38.35
1-Wochen-Bereich:
$33.81
$39.99
52-Wochen-Spanne:
$18.92
$50.60
Viking Therapeutics Inc Stock (VKTX) Company Profile
Firmenname
Viking Therapeutics Inc
Sektor
Branche
Telefon
858-704-4660
Adresse
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Vergleichen Sie VKTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
37.53 | 4.29B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.54 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.82 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.91 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.83 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.92 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-29 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Goldman | Neutral |
| 2025-02-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-07 | Eingeleitet | Citigroup | Neutral |
| 2024-12-02 | Eingeleitet | Piper Sandler | Overweight |
| 2024-11-22 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-04 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-11 | Eingeleitet | JP Morgan | Overweight |
| 2024-06-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | Bestätigt | Oppenheimer | Outperform |
| 2024-03-07 | Eingeleitet | Jefferies | Buy |
| 2024-02-28 | Bestätigt | Oppenheimer | Outperform |
| 2023-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2023-03-28 | Bestätigt | Maxim Group | Buy |
| 2023-03-17 | Eingeleitet | Stifel | Buy |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-05-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-05-01 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-25 | Eingeleitet | Stifel | Buy |
| 2019-03-29 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | Bestätigt | Maxim Group | Buy |
| 2019-02-22 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-11-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-18 | Bestätigt | Maxim Group | Buy |
| 2018-09-18 | Bestätigt | Raymond James | Outperform |
| 2018-07-20 | Eingeleitet | SunTrust | Buy |
| 2018-06-28 | Eingeleitet | Raymond James | Outperform |
| 2018-06-01 | Bestätigt | Laidlaw | Buy |
| 2018-05-31 | Bestätigt | Maxim Group | Buy |
| 2018-03-26 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-11-28 | Bestätigt | Maxim Group | Buy |
| 2017-11-21 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
Major Investors Pile Into Viking Therapeutics Stock - AD HOC NEWS
Looking At Viking Therapeutics's Recent Unusual Options Activity - Benzinga
460,415 Shares in Viking Therapeutics, Inc. $VKTX Acquired by Jump Financial LLC - MarketBeat
Franklin Resources Inc. Has $703,000 Stock Holdings in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics (VKTX): Valuation Check After Faster-Than-Expected Enrollment in Key Obesity Drug Trial - simplywall.st
Norges Bank Takes $46.85 Million Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics: Analysts Project Stock Could More Than Double - AD HOC NEWS
Viking Therapeutics: Prepping For A Critical 2026 - Seeking Alpha
Viking Therapeutics (NASDAQ:VKTX) Shares Up 9.4%Here's Why - MarketBeat
Schroder Investment Management Group Buys 150,470 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Will Viking Therapeutics Inc. stock outperform Nasdaq index2025 AllTime Highs & Verified Chart Pattern Trade Signals - Newser
Will Viking Therapeutics Inc. stock outperform international peersEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
What's Up With The Jump In Viking Therapeutics Stock? - Benzinga
The FDA Is Shaking Things Up; Biotech, Research Stocks Diverge - Investor's Business Daily
How Viking Therapeutics Inc. (1VT) stock expands through international marketsTrade Ideas & Weekly Breakout Opportunity Watchlist - Newser
What consensus target says about Viking Therapeutics Inc. (1VT) stockMarket Performance Summary & Daily Entry Point Alerts - Newser
Will Viking Therapeutics Inc. stock benefit from sector rotationJuly 2025 Big Picture & Low Drawdown Trading Techniques - Newser
Viking Therapeutics Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
How Viking Therapeutics Inc. stock responds to policy changesBuy Signal & Growth Oriented Trade Recommendations - Newser
Viking Therapeutics Stock Gains Momentum on Clinical Progress - AD HOC NEWS
42,134 Shares in Viking Therapeutics, Inc. $VKTX Purchased by Scotia Capital Inc. - MarketBeat
Why Viking Therapeutics Inc. stock appeals to analysts2025 Pullback Review & Stock Portfolio Risk Management - Newser
Will Viking Therapeutics Inc. (1VT) stock deliver compounding returnsJuly 2025 Setups & Expert Curated Trade Setups - Newser
What margin trends mean for Viking Therapeutics Inc. stockEntry Point & Fast Moving Market Watchlists - Newser
Is There a Future for Viking Therapeutics? - AOL.com
The Bull Case For Viking Therapeutics (VKTX) Could Change Following Early Completion and Positive Data in Obesity Trial - simplywall.st
Viking Therapeutics Emerges as a Prime Acquisition Candidate Amid Obesity Drug Advancements - AD HOC NEWS
XTX Topco Ltd Acquires Shares of 36,199 Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics, Inc. (VKTX) Options Chain - Yahoo! Finance Canada
Why Viking Therapeutics Inc. (1VT) stock attracts HNW investorsQuarterly Trade Report & Proven Capital Preservation Methods - Newser
VKTX Stock Rises 34% in Three Months: Here's What You Should Know - sharewise.com
Viking Therapeutics Emerges as a Prime Acquisition Target Following Trial Success - AD HOC NEWS
(VKTX) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Viking Therapeutics Stock Gains Momentum on Clinical Trial Milestone - Ad-hoc-news.de
Assessing Viking Therapeutics (VKTX) Valuation After Recent Share Price Recovery - Yahoo Finance
Ensign Peak Advisors Inc Trims Stake in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics (VKTX): Evaluating Valuation After Key Phase 3 Obesity Trial Milestone and New Clinical Data - Sahm
Viking Therapeutics: A Clash of Convictions - Ad-hoc-news.de
SG Americas Securities LLC Makes New $379,000 Investment in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating - Finviz
Tejara Capital Ltd Purchases 30,097 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
What drives Viking Therapeutics Inc stock pricePrice Channel Trading & Small Entry Cost Trading - earlytimes.in
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? - Finviz
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Is Viking Therapeutics Inc. stock a good choice for value investorsRisk Management & Low Drawdown Momentum Ideas - BỘ NỘI VỤ
Why Viking Therapeutics Inc. stock remains undervaluedJuly 2025 Sentiment & Daily Stock Trend Watchlist - BỘ NỘI VỤ
Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 - Finviz
Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 - The Motley Fool
Viking Therapeutics: A Stock at a Crossroads - Ad-hoc-news.de
Market Catalysts: What momentum indicators show for Viking Therapeutics Inc. stockJuly 2025 Sentiment & High Return Trade Guides - moha.gov.vn
12,059 Shares in Viking Therapeutics, Inc. $VKTX Acquired by Entropy Technologies LP - MarketBeat
Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):